American Journal of Cardiology
Volume 102, Issue 5 , Pages 546-551 , 1 September 2008

Impact of Perioperative Myocardial Infarction on Angiographic and Clinical Outcomes Following Coronary Artery Bypass Grafting (from PRoject of Ex-vivo Vein graft ENgineering via Transfection [PREVENT] IV)

  • James M. Yau, MD

      Affiliations

    • Duke University Medical Center, Durham, North Carolina
  • ,
  • John H. Alexander, MD, MHS

      Affiliations

    • Duke University Medical Center, Durham, North Carolina
    • Duke Clinical Research Institute, Durham, North Carolina
    • Corresponding Author InformationCorresponding author: Tel: 919-668-8955; Fax: 919-668-7085
  • ,
  • Gail Hafley, MS

      Affiliations

    • Duke Clinical Research Institute, Durham, North Carolina
  • ,
  • Kenneth W. Mahaffey, MD

      Affiliations

    • Duke University Medical Center, Durham, North Carolina
    • Duke Clinical Research Institute, Durham, North Carolina
  • ,
  • Michael J. Mack, MD

      Affiliations

    • Cardiopulmonary Research Science & Technology Institute, Dallas, Texas
  • ,
  • Nicholas Kouchoukos, MD

      Affiliations

    • Missouri Baptist Medical Center, St. Louis, Missouri
  • ,
  • Abhinav Goyal, MD, MHS

      Affiliations

    • Duke University Medical Center, Durham, North Carolina
    • Duke Clinical Research Institute, Durham, North Carolina
  • ,
  • Eric D. Peterson, MD, MPH

      Affiliations

    • Duke University Medical Center, Durham, North Carolina
    • Duke Clinical Research Institute, Durham, North Carolina
  • ,
  • C. Michael Gibson, MD

      Affiliations

    • PERFUSE Angiographic Laboratory, Boston, Massachusetts
  • ,
  • Robert M. Califf, MD

      Affiliations

    • Duke University Medical Center, Durham, North Carolina
    • Duke Clinical Research Institute, Durham, North Carolina
  • ,
  • Robert A. Harrington, MD

      Affiliations

    • Duke University Medical Center, Durham, North Carolina
    • Duke Clinical Research Institute, Durham, North Carolina
  • ,
  • T. Bruce Ferguson, MD

      Affiliations

    • East Carolina State University, Greenville, North Carolina
  • ,
  • PREVENT IV Investigators

Received 11 February 2008 ,Revised 17 April 2008 ,Accepted 17 April 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 This work was supported by the Duke Clinical Research Institute, Durham, North Carolina. The PREVENT-IV Trial was supported by Corgentech Inc., South San Francisco, California. Dr. Alexander, G. Hafley, Dr. Mahaffey, Dr. Mack, Dr. Kouchoukos, Dr. Goyal, Dr. Peterson, Dr. Gibson, Dr. Califf, Dr. Harrington, and Dr. Ferguson received research funding from Corgentech Inc. for their participation in PREVENT IV.

PII: S0002-9149(08)00748-0

doi: 10.1016/j.amjcard.2008.04.069

American Journal of Cardiology
Volume 102, Issue 5 , Pages 546-551 , 1 September 2008